Tuesday, September 29, 2026

Search
HomeBusiness NewsPuma Biotechnology Presents Data from the Neratinib Arm of the INSIGhT Trial...
Business News

Puma Biotechnology Presents Data from the Neratinib Arm of the INSIGhT Trial at the 2021 SNO Annual …

0
2
- Advertisement -


LOS ANGELES–()–Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced that investigators presented results from the neratinib arm of the Phase II Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT Trial) at the 2021 Society…



Click here to view the original article.

- Advertisment -
Previous article
NT communities of Binjari and Rockhole placed into hard lockdown over COVID cases
Next article
How campers’ killer escaped from crime scene

RELATED ARTICLES

- Advertisement -

Recently Viewed

Load more

FEATURED

POPULAR POSTS

POPULAR CATEGORY

The Australian Online News Network acknowledges the traditional custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.

FOLLOW US

© 2024 Australian Online News | Privacy Policy